| Crohn Disease |
1 |
1 |
| Biosimilars |
0 |
0.99 |
| Colitis |
0 |
0.57 |
| Biologic Therapy |
0 |
0.45 |
| Ulcerative Colitis |
0 |
0.44 |
| Inflammatory Bowel Disease |
0 |
0.36 |
| Europe |
0 |
0.29 |
| Meta-Analysis |
0 |
0.98 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.2 |
| Allergens |
0 |
0.14 |
| CT Scan |
0 |
0.14 |
| Food and Drug Administration (FDA) |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| Intravenous |
0 |
0.14 |
| NHS |
0 |
0.14 |
| Remission |
0 |
0.14 |
| Tumor |
0 |
0.14 |